| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Exploratory Analysis of Pharmaceutical Drugs as Basic Research Tools
|
Calfee, John E.
|
|
2012
|
46 |
2 |
p. 192-196
|
artikel
|
| 2 |
An Exploratory Analysis of Pharmaceutical Drugs as Basic Research Tools
|
Calfee, John E.
|
|
|
46 |
2 |
p. 192-196
|
artikel
|
| 3 |
Associate Editor’s Commentary: PEEKABOO—ETASU!
|
Pitts, Peter J.
|
|
2012
|
46 |
2 |
p. 158-159
|
artikel
|
| 4 |
Associate Editor’s Commentary: PEEKABOO—ETASU!
|
Pitts, Peter J.
|
|
|
46 |
2 |
p. 158-159
|
artikel
|
| 5 |
Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products
|
Nicholas, J. Michael
|
|
2012
|
46 |
2 |
p. 197-206
|
artikel
|
| 6 |
Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products
|
Nicholas, J. Michael
|
|
|
46 |
2 |
p. 197-206
|
artikel
|
| 7 |
Consumer Dynamics in a Nonmature Generic Drugs Market: A Causal Model Explaining Intention to Purchase in Spain
|
Gómez, Mónica
|
|
2012
|
46 |
2 |
p. 207-215
|
artikel
|
| 8 |
Consumer Dynamics in a Nonmature Generic Drugs Market: A Causal Model Explaining Intention to Purchase in Spain
|
Gómez, Mónica
|
|
|
46 |
2 |
p. 207-215
|
artikel
|
| 9 |
Content Analysis of Television Advertising for Drugs That Switch From Prescription to Over-the-Counter: Balancing Information and Appeals
|
Faerber, Adrienne E.
|
|
2012
|
46 |
2 |
p. 226-234
|
artikel
|
| 10 |
Content Analysis of Television Advertising for Drugs That Switch From Prescription to Over-the-Counter: Balancing Information and Appeals
|
Faerber, Adrienne E.
|
|
|
46 |
2 |
p. 226-234
|
artikel
|
| 11 |
Editor’s Commentary: Ethics in Clinical Research
|
Turner, J. Rick
|
|
2012
|
46 |
2 |
p. 155-157
|
artikel
|
| 12 |
Editor’s Commentary: Ethics in Clinical Research
|
Turner, J. Rick
|
|
|
46 |
2 |
p. 155-157
|
artikel
|
| 13 |
2012 EuroMeeting Student Poster Abstracts
|
|
|
2012
|
46 |
2 |
p. 264-271
|
artikel
|
| 14 |
2012 EuroMeeting Student Poster Abstracts
|
|
|
|
46 |
2 |
p. 264-271
|
artikel
|
| 15 |
Industry Support of Key Opinion Leaders
|
Neglia, Elizabeth
|
|
2012
|
46 |
2 |
p. 180-184
|
artikel
|
| 16 |
Industry Support of Key Opinion Leaders
|
Neglia, Elizabeth
|
|
|
46 |
2 |
p. 180-184
|
artikel
|
| 17 |
Practical Considerations and Strategies for Executing Adaptive Clinical Trials
|
He, Weili
|
|
2012
|
46 |
2 |
p. 160-174
|
artikel
|
| 18 |
Practical Considerations and Strategies for Executing Adaptive Clinical Trials
|
He, Weili
|
|
|
46 |
2 |
p. 160-174
|
artikel
|
| 19 |
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs
|
Sasinowski, Frank J.
|
|
2012
|
46 |
2 |
p. 238-263
|
artikel
|
| 20 |
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs
|
Sasinowski, Frank J.
|
|
|
46 |
2 |
p. 238-263
|
artikel
|
| 21 |
Review of Genotoxic Impurities: Strategies for Identification and Control
|
Allio, Theresa
|
|
2012
|
46 |
2 |
p. 235-236
|
artikel
|
| 22 |
Review of Genotoxic Impurities: Strategies for Identification and Control
|
Allio, Theresa
|
|
|
46 |
2 |
p. 235-236
|
artikel
|
| 23 |
Review of Translational Medicine and Drug Discovery
|
Tabor, Edward
|
|
2012
|
46 |
2 |
p. 237-237
|
artikel
|
| 24 |
Review of Translational Medicine and Drug Discovery
|
Tabor, Edward
|
|
|
46 |
2 |
p. 237
|
artikel
|
| 25 |
Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force
|
Gliklich, Richard
|
|
2012
|
46 |
2 |
p. 185-191
|
artikel
|
| 26 |
Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force
|
Gliklich, Richard
|
|
|
46 |
2 |
p. 185-191
|
artikel
|
| 27 |
Testing in a Prespecified Subgroup and the Intent-to-Treat Population
|
Rothmann, Mark D.
|
|
2012
|
46 |
2 |
p. 175-179
|
artikel
|
| 28 |
Testing in a Prespecified Subgroup and the Intent-to-Treat Population
|
Rothmann, Mark D.
|
|
|
46 |
2 |
p. 175-179
|
artikel
|
| 29 |
Transparency in Drug Submission Processes of 3 Asian Countries: A Survey of Industry Views
|
Solberg, Martin
|
|
2012
|
46 |
2 |
p. 216-225
|
artikel
|
| 30 |
Transparency in Drug Submission Processes of 3 Asian Countries: A Survey of Industry Views
|
Solberg, Martin
|
|
|
46 |
2 |
p. 216-225
|
artikel
|
Tijdschrift beschrijving